Beliefs about methadone in an inner-city methadone clinic

Journal of Urban Health

Volumn 79, Issue 4, 2002, Pages 571-578

  Stancliff, Sharon ^a   Myers, Julie Elana ^b   Steiner, Stuart ^a   Drucker, Ernest ^c  

^a Harlem East Life Plan   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Addiction; Drug treatment; Heroin; HIV; Injection drug use; Methadone; New York City

Indexed keywords

METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADDICTION; ADULT; AGED; ARTICLE; ATTITUDE; EXPERIENCE; FEMALE; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SEROCONVERSION;

ADULT; ATTITUDE TO HEALTH; FEMALE; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; METHADONE; MIDDLE AGED; NEW YORK CITY; POVERTY; QUESTIONNAIRES; SUBSTANCE ABUSE, INTRAVENOUS; URBAN HEALTH SERVICES;

EID: 0036951539     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1093/jurban/79.4.571     Document Type: Article

References (24)

1. National Institutes of Health. Effective medical treatment of opiate addiction. NIH Consensus Statement Online 1997 November 17-19;15(6):1-38. Available at: http://odp. od.nih.gov/consensus/cons/108/108_statement.htm#3. Date accessed: April 22, 2002.
2. Drucker E, Lurie P, Wodak A, Alcabes P. Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS. 1998;12(suppl A):S217-S230.
3. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113(suppl 1):97-106.
4. Caplehorn JR, Dalton MS, Cluff MC, Petrenas AM. Retention in methadone maintenance and heroin addicts' risk of death. Addiction. 1994;89:203-209.
5. Laine C, Markson LE, McKee LJ, Hauck WW, Fanning TR, Turner BJ. The relationship of clinic experience with advanced HIV and survival of women with AIDS. AIDS. 1998;12:417-424.
6. Newschaffer CJ, Laine C, Hauck WW, Fanning T, Turner BJ. Clinic characteristics associated with reduced hospitalization of drug users with AIDS. J Urban Health. 1998;75:153-169.
7. Centers for Disease Control and Prevention. HIV/AIDS Surveill Rep. 2000;12(1).
8. Bureau of HIV/AIDS Epidemiology, New York State Department of Health. AIDS Surveillance Quarterly Update: Cases Reported Through June, 2000. Albany, NY: New York State Department of Health; 2000.
9. Opioid drugs in maintenance and detoxification treatment of opiate addiction; final rule. Substance Abuse and Mental Health Services Administration. 66 (11) Federal Register (Wednesday, January 17, 2001), Rules and Regulations.
10. Goldsmith DS, Hunt DE, Lipton DS, Strug DL. Methadone folklore: Beliefs about side effects and their impact on treatment. Hum Organ. 1984;43:330-340.
11. Hunt DE, Lipton DS, Goldsmith DS, Strug DL, Spunt B. "It takes your heart": The image of methadone maintenance in the addict world and its effect on recruitment into treatment. Int J Addict. 1985;20:1751-1771.
12. Rosenblum A, Magura S, Joseph H. Ambivalence toward methadone treatment among intravenous drug users. J Psychoactive Drugs. 1991;23:21-27.
13. Murphy S, Irwin J. "Living with the dirty secret": Problems of disclosure for methadone maintenance clients. J Psychoactive Drugs. 1992;24:257-264.
14. Zule WA, Desmond DP. Attitudes toward methadone maintenance: Implications for HIV prevention. J Psychoactive Drugs. 1998;30:89-97.
15. D'Aunno T, Folz-Murphy N, Lin X. Changes in methadone treatment practices: Results from a panel study, 1988-1995. Am J Drug Alcohol Abuse. 1999;25:681-699.
16. New York State Department of Health, AIDS Institute. Community Need Index for New York City HSA Region. Albany, NY: New York State Department of Health; 1995.
17. Rhoades HM, Creson D, Elk R, Schmitz J, Grabowski J. Retention, HIV risk, and illicit drug use during treatment: Methadone dose and visit frequency. Am J Public Health. 1998;88:34-39.
18. Rettig RA, Yarmolinsky A, eds. Federal Regulation of Methadone Treatment. Washington, DC: National Academy Press; 1995.
19. Narcotics Anonymous. World Services Regarding Methadone and Other Drug Replacement Programs. World Service Board of Trustees. Bulletin 29. Available at: www.na.org/bull29.htm. Date accessed: April 22, 2002.
20. Koch M, Banys P. Liver transplantation and opioid dependence. JAMA. 2001;285:1056-1058.
21. Caplehorn JR, Irwig L, Saunders JB. Attitudes and beliefs of staff working in methadone maintenance clinics. Subst Use Misuse. 1996;31:437-452.
22. Caplehorn JR, Hartel DM, Irwig L. Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Subst Use Misuse. 1997;32:399-413.
23. Magura S, Rosenblum A. Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. Mt Sinai J Med. 2001;68:62-74.
24. Frank B. An overview of heroin trends in New York City: Past, present and future. Mt Sinai J Med. 2000;67:340-346.